These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16326746)

  • 1. Role of inflammatory cells in the kidney in the induction and maintenance of hypertension.
    Rodriguez-Iturbe B; Johnson RJ
    Nephrol Dial Transplant; 2006 Feb; 21(2):260-3. PubMed ID: 16326746
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of immunocompetent cell renal infiltration in the pathogenesis of arterial hypertension].
    Rodríguez-Iturbe B
    Nefrologia; 2008; 28(5):483-92. PubMed ID: 18816206
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte-renal epithelial cell interactions regulate lupus nephritis.
    Kelley VR
    Semin Nephrol; 2007 Jan; 27(1):59-68. PubMed ID: 17336689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-immunologic studies in hypertension, chronic nephritis and pyelonephritis].
    Andrenko PT
    Vrach Delo; 1971 Nov; 11():106-9. PubMed ID: 5143252
    [No Abstract]   [Full Text] [Related]  

  • 5. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.
    Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C
    Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrolithiasis complicated with interstitial nephritis as cause of arterial hypertension].
    STAPOR K
    Pol Tyg Lek (Wars); 1957 Apr; 12(18):686-90. PubMed ID: 13452990
    [No Abstract]   [Full Text] [Related]  

  • 7. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of plasminogen does not alter the early inflammatory response following a tympanic membrane perforation: a study in plasminogen-deficient mice.
    Prestwich AH; Li J; Eriksson PO; Ny T; Berggren D; Hellström S
    Acta Otolaryngol; 2008; 128(12):1294-302. PubMed ID: 18781446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney.
    Esteban V; Gallego-Delgado J; Lazaro A; Osende J; Mezzano S; Egido J; Ruiz-Ortega M
    J Nephrol; 2006; 19(6):725-31. PubMed ID: 17173244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells and inflammatory kidney disease.
    Blank U; Essig M; Scandiuzzi L; Benhamou M; Kanamaru Y
    Immunol Rev; 2007 Jun; 217():79-95. PubMed ID: 17498053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of macrophages and lymphocytes on the survival and axon regeneration of injured retinal ganglion cells in rats from different autoimmune backgrounds.
    Luo JM; Zhi Y; Chen Q; Cen LP; Zhang CW; Lam DS; Harvey AR; Cui Q
    Eur J Neurosci; 2007 Dec; 26(12):3475-85. PubMed ID: 18052979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of renal inflammation: therapeutic strategies.
    Karkar A
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):1-19. PubMed ID: 18087117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Induction of inflammatory gene expression by THP-1 macrophages cultured in normocholesterolaemic hypertensive sera and modulatory effects of green tea polyphenols'.
    Mahajan N; Dhawan V; Sharma G; Jain S; Kaul D
    J Hum Hypertens; 2008 Feb; 22(2):141-3. PubMed ID: 17728801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
    Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
    Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of interstitial nephritis in pigs with naturally occurring postweaning multisystemic wasting syndrome.
    Sarli G; Mandrioli L; Panarese S; Brunetti B; Segalés J; Domínguez J; Marcato PS
    Vet Pathol; 2008 Jan; 45(1):12-8. PubMed ID: 18192569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis.
    Du Y; Fu Y; Mohan C
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):31-40. PubMed ID: 18250969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists.
    Li L; Okusa MD
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):432-44. PubMed ID: 16932478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.